Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cabozantinib and Nivolumab Among Older Patients With Renal-cell Carcinoma, a Prospective Cohort With Geriatric, Pharmacologic and Patient-reported-outcome Evaluation

Authors not listed

Gustave Roussy, Cancer Campus, Grand Paris · 2025

Abstract

The goal of the study is to describe real-life use and exposition to nivolumab-cabozantinib among older patients with metastatic clear-cell renal cell cancer

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-01 MST

Cite this

APA
Anonymous. (2025). Cabozantinib and Nivolumab Among Older Patients With Renal-cell Carcinoma, a Prospective Cohort With Geriatric, Pharmacologic and Patient-reported-outcome Evaluation. <em>Gustave Roussy, Cancer Campus, Grand Paris</em>. https://clinicaltrials.gov/study/NCT06934057
Vancouver
Anonymous. Cabozantinib and Nivolumab Among Older Patients With Renal-cell Carcinoma, a Prospective Cohort With Geriatric, Pharmacologic and Patient-reported-outcome Evaluation. Gustave Roussy, Cancer Campus, Grand Paris. 2025.
BibTeX
@misc{anon2025Caboza, title = {Cabozantinib and Nivolumab Among Older Patients With Renal-cell Carcinoma, a Prospective Cohort With Geriatric, Pharmacologic and Patient-reported-outcome Evaluation}, author = {Anonymous}, journal = {Gustave Roussy, Cancer Campus, Grand Paris}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings